226 - Poster Session A
Hypomethylation signature enriches stem properties and predicts poor prognosis for ovarian cancer patients
Hypomethylation signature enriches stem properties and predicts poor prognosis for ovarian cancer patients
Saturday, March 22, 2014: 2:25 PM
West Exhibit Hall (Tampa Convention Center)